Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
2.375
+0.005 (0.21%)
Aug 3, 2026, 11:32 AM EDT - Market open
Organogenesis Holdings Employees
Organogenesis Holdings had 854 employees as of December 31, 2025. The number of employees decreased by 15 or -1.73% compared to the previous year.
Employees
854
Change (1Y)
-15
Growth (1Y)
-1.73%
Revenue / Employee
$602,698
Profits / Employee
-$17,033
Market Cap
305.60M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 854 | -15 | -1.73% |
| Dec 31, 2024 | 869 | 7 | 0.81% |
| Dec 31, 2023 | 862 | -168 | -16.31% |
| Dec 31, 2022 | 1,030 | 80 | 8.42% |
| Dec 31, 2021 | 950 | 40 | 4.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2001 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2000 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Canopy Growth | 1,128 |
| Emergent BioSolutions | 900 |
| Kamada | 462 |
| Evolus | 350 |
| Anika Therapeutics | 235 |
| Akebia Therapeutics | 194 |
| Alpha Teknova | 158 |
| Aquestive Therapeutics | 147 |
ORGO News
- 6 days ago - Organogenesis Affinity meets primary endpoint in complex venous leg ulcer trial - TheFly
- 6 days ago - Organogenesis Announces Publication of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit of Affinity™ in the Most Challenging and Complex Venous Leg Ulcers - GlobeNewsWire
- 25 days ago - Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026 - GlobeNewsWire
- 27 days ago - Organogenesis announces FDA acceptance of ReNu biologics license application - TheFly
- 27 days ago - Organogenesis Announces FDA Acceptance of Biologics License Application for ReNu® for the Management of Symptomatic Knee Osteoarthritis - GlobeNewsWire
- 7 weeks ago - Organogenesis Holdings Transcript: AGM 2026 - Transcripts
- 2 months ago - Organogenesis initiated with a Hold at Truist - TheFly
- 3 months ago - Organogenesis downgraded to Neutral from Buy at BTIG - TheFly